[go: up one dir, main page]

GT199600098A - Formulaciones de quinolona inyectables. - Google Patents

Formulaciones de quinolona inyectables.

Info

Publication number
GT199600098A
GT199600098A GT199600098A GT199600098A GT199600098A GT 199600098 A GT199600098 A GT 199600098A GT 199600098 A GT199600098 A GT 199600098A GT 199600098 A GT199600098 A GT 199600098A GT 199600098 A GT199600098 A GT 199600098A
Authority
GT
Guatemala
Prior art keywords
injectable
complementary
quinolone
formulations
injection
Prior art date
Application number
GT199600098A
Other languages
English (en)
Inventor
Wayne Alan Boettner
Peter Connor Canning
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21735307&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GT199600098(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of GT199600098A publication Critical patent/GT199600098A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4995—Pyrazines or piperazines forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

UNA SOLUCION FARMACEUTICA ACUOSA QUE ES ADECUADA PARA INYECCION EN UN HUESPED, QUE COMPRENDE DANOFLOXACINA O UNA DE SUS SALES FARMACEUTICAMENTE ACEPTABLES EN UNA CANTIDAD SUFICIENTE PARA EL TRATAMIENTO DE INFECCIONES BACTERIANAS Y, (1) UN COMPUESTO DE MAGNESIO O, (2) UN COMPUESTO DE CINC MEZCLADO CON UN DISOLVENTE COMPLEMENTARIO, ESTANDO PRESENTES DICHOS COMPUESTOS Y DICHOS DISOLVENTES COMPLEMENTARIOS EN CANTIDADES QUE SON SUFICIENTES PARA MEJORAR LA TOLERANCIA EN EL SITIO DE LA INYECCION. LA DANOFLOXACINA ES EL ACIDO 1CICLOPROPIL6FLUORO7{(1S, 4S)5METIL2.5DIAZABICICLO [2.2.1] HEPT2IL} 4OXO3QUINOLIN CARBOXILICO.
GT199600098A 1995-12-21 1996-12-19 Formulaciones de quinolona inyectables. GT199600098A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US905295P 1995-12-21 1995-12-21

Publications (1)

Publication Number Publication Date
GT199600098A true GT199600098A (es) 1998-06-12

Family

ID=21735307

Family Applications (1)

Application Number Title Priority Date Filing Date
GT199600098A GT199600098A (es) 1995-12-21 1996-12-19 Formulaciones de quinolona inyectables.

Country Status (42)

Country Link
US (1) US5811130A (es)
EP (1) EP0868183B1 (es)
JP (1) JP3416145B2 (es)
KR (1) KR100402570B1 (es)
CN (1) CN1104899C (es)
AP (1) AP706A (es)
AR (1) AR005147A1 (es)
AT (1) ATE212551T1 (es)
AU (1) AU709474B2 (es)
BG (1) BG63933B1 (es)
BR (1) BR9612230A (es)
CA (1) CA2239352C (es)
CO (1) CO4480098A1 (es)
CZ (1) CZ293747B6 (es)
DE (1) DE69618987T2 (es)
DK (1) DK0868183T3 (es)
DZ (1) DZ2146A1 (es)
EG (1) EG24071A (es)
ES (1) ES2167609T3 (es)
GT (1) GT199600098A (es)
HR (1) HRP960607B1 (es)
HU (1) HU227918B1 (es)
IL (1) IL124454A (es)
IS (1) IS2010B (es)
MA (1) MA24035A1 (es)
MX (1) MX9805026A (es)
MY (1) MY117109A (es)
NO (1) NO315734B1 (es)
NZ (2) NZ320545A (es)
OA (1) OA10697A (es)
PE (1) PE25798A1 (es)
PL (1) PL186795B1 (es)
PT (1) PT868183E (es)
RS (1) RS49523B (es)
RU (1) RU2141827C1 (es)
SI (1) SI0868183T1 (es)
SK (1) SK284412B6 (es)
TN (1) TNSN96163A1 (es)
TW (1) TW449475B (es)
UA (1) UA56151C2 (es)
WO (1) WO1997023217A1 (es)
ZA (1) ZA9610780B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID21415A (id) * 1997-12-05 1999-06-10 Upjohn Co Senyawa-senyawa antibiotik magnesium quinolon
US6017948A (en) * 1998-10-30 2000-01-25 Supergen, Inc. Water-miscible pharmaceutical compositions
DE19937116A1 (de) * 1999-08-06 2001-02-08 Bayer Ag Moxifloxacin Kochsalzformulierung
DE19937115A1 (de) 1999-08-06 2001-02-08 Bayer Ag Wäßrige Arzneimittelformulierung von Moxifloxacin oder Salzen davon
AU2001228454A1 (en) * 2000-01-13 2001-07-24 Merck Patent G.M.B.H Pharmaceutical preparations containing 2-pyrrolidone as the dissolving intermediary
CA2433037C (en) 2000-12-28 2010-12-21 Takeda Chemical Industries, Ltd. Sustained-release preparation
US20040127537A1 (en) * 2002-06-26 2004-07-01 Gokarn Yatin R. Stable liquid parenteral parecoxib formulation
JPWO2006004028A1 (ja) * 2004-07-02 2008-04-24 第一製薬株式会社 キノロン含有医薬組成物
US8546423B2 (en) 2005-05-18 2013-10-01 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
DK1901749T3 (en) * 2005-05-18 2016-10-24 Raptor Pharmaceuticals Inc Aerosolized fluoroquinolones AND USES THEREOF
FR2896416B1 (fr) 2006-01-24 2010-08-13 Vetoquinol Composition anti-infectieuse comprenant un compose de type pyrido (3,2,1-ij)-benzoxadiazine
ES2671342T3 (es) * 2006-02-10 2018-06-06 Pari Pharma Gmbh Antibióticos nebulizados para terapia de inhalación
US20070197548A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone compositions
DE102006010643A1 (de) 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Arzneimittel enthaltend Fluorchinolone
DE102006010642A1 (de) * 2006-03-08 2007-09-27 Bayer Healthcare Aktiengesellschaft Arzneimittelformulierungen, enthaltend Fluorchinolone
MX2007009796A (es) 2007-08-14 2009-02-25 Cell Therapy And Technology S Gel conteniendo pirfenidona.
CN105520922A (zh) 2008-10-07 2016-04-27 拉普特制药有限公司 用于改进的药物动力学的氟喹诺酮气雾剂制剂
PT2346509T (pt) 2008-10-07 2020-08-05 Horizon Orphan Llc Inalação de levofloxacina para redução da inflamação pulmonar
PT2473170T (pt) 2009-09-04 2019-08-23 Horizon Orphan Llc Utilização de levofloxacina em aerossol para tratamento de fibrose cística
MX2011007675A (es) 2011-07-19 2012-07-11 Cell Therapy And Technology S A De C V Procedimiento para la fabricacion de una composicion farmaceutica en forma de tabletas de liberacion prolongada conteniendo pirfenidona y su aplicacion en la regresion de la insuficiencia renal cronica, contractura capsular mamaria y fibrosis hepatica humanas.
MX346763B (es) 2012-03-28 2017-03-31 Cell Therapy And Tech S A De C V Composición tópica semisólida conteniendo pirfenidona y dialil óxido de disulfuro modificado (odd-m) para eliminar o prevenir el acné.
MX356551B (es) 2012-08-23 2018-06-04 Grupo Medifarma S A De C V Star Composición antiséptica, antiseborreica y exfoliante para eliminar o prevenir el acné.
WO2016195014A1 (ja) 2015-06-02 2016-12-08 杏林製薬株式会社 水性液剤
US10406149B2 (en) 2015-06-02 2019-09-10 Kyorin Pharmaceutical Co., Ltd. Aqueous liquid formulation
EP3305295A4 (en) 2015-06-02 2019-02-20 Kyorin Pharmaceutical Co., Ltd. AQUEOUS MEDICINE
RU2019128568A (ru) * 2017-02-13 2021-03-15 Байер Энимэл Хельс ГмбХ Жидкая композиция, содержащая прадофлоксацин
MX366086B (es) 2017-08-15 2019-06-27 Cell Therapy And Tech S A De C V Composicion topica semisolida conteniendo un agente antimicrobiano y pirfenidona para el tratamiento de daños cronicos de la piel.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US523505A (en) * 1894-07-24 Island
DE3517709A1 (de) * 1985-01-05 1986-07-10 Bayer Ag Basische zubereitungen von chinoloncarbonsaeuren
JPS63188626A (ja) * 1987-01-30 1988-08-04 Dainippon Pharmaceut Co Ltd ピリドンカルボン酸の可溶化方法
DE3902079A1 (de) * 1988-04-15 1989-10-26 Bayer Ag I.m. injektionsformen von gyrase-inhibitoren
EP0507851B1 (en) * 1989-12-29 1997-04-02 Abbott Laboratories Quinolone carboxylic acid--metal ion--acid complexes
US5084276A (en) * 1990-01-05 1992-01-28 Abbott Laboratories Quinolone carboxylic acid compositions with polymeric additive to reduce vein irritation
DE69102900T3 (de) * 1990-02-14 1998-04-09 Otsuka Pharma Co Ltd Brausemischung, deren Herstellung sowie Verwendung.
FR2665635A1 (fr) * 1990-08-10 1992-02-14 Merck Sharp & Dohme Composition pharmaceutique fluide a base d'un complexe metallique et son procede de preparation.
US5082863A (en) * 1990-08-29 1992-01-21 Schering Corporation Pharmaceutical composition of florfenicol
US5235054A (en) * 1992-07-15 1993-08-10 Pfizer Inc. 3-carboxaldehyde substituted quinolines and naphthyridines
JPH0782141A (ja) * 1993-09-17 1995-03-28 Tanabe Seiyaku Co Ltd 動物用注射剤

Also Published As

Publication number Publication date
NO982842D0 (no) 1998-06-19
HUP9903726A3 (en) 2001-01-29
IL124454A0 (en) 1998-12-06
JPH11501331A (ja) 1999-02-02
OA10697A (en) 2001-05-04
DE69618987D1 (de) 2002-03-14
HRP960607A2 (en) 1998-06-30
PT868183E (pt) 2002-06-28
CZ293747B6 (cs) 2004-07-14
IL124454A (en) 2003-10-31
CO4480098A1 (es) 1997-07-09
PL328001A1 (en) 1999-01-04
SK80798A3 (en) 1999-09-10
YU69096A (sh) 1999-06-15
CA2239352C (en) 2002-06-04
AP9600898A0 (en) 1997-01-31
RU2141827C1 (ru) 1999-11-27
ES2167609T3 (es) 2002-05-16
BG63933B1 (bg) 2003-07-31
RS49523B (sr) 2006-10-27
AP706A (en) 1998-12-04
AU709474B2 (en) 1999-08-26
BG102542A (en) 1999-06-30
TNSN96163A1 (fr) 2005-03-15
ZA9610780B (en) 1998-06-22
HU227918B1 (en) 2012-06-28
BR9612230A (pt) 1999-07-13
IS4755A (is) 1998-05-25
WO1997023217A1 (en) 1997-07-03
DE69618987T2 (de) 2002-11-21
US5811130A (en) 1998-09-22
NO315734B1 (no) 2003-10-20
EG24071A (en) 2008-05-11
SK284412B6 (sk) 2005-03-04
KR100402570B1 (ko) 2003-12-18
EP0868183A1 (en) 1998-10-07
AU7328996A (en) 1997-07-17
HRP960607B1 (en) 2002-06-30
PE25798A1 (es) 1998-05-21
NZ320545A (en) 2000-03-27
KR19990076617A (ko) 1999-10-15
CZ193098A3 (cs) 1999-05-12
NZ501160A (en) 2001-10-26
NO982842L (no) 1998-06-19
PL186795B1 (pl) 2004-02-27
CA2239352A1 (en) 1997-07-03
MY117109A (en) 2004-05-31
DK0868183T3 (da) 2002-03-25
CN1205636A (zh) 1999-01-20
EP0868183B1 (en) 2002-01-30
JP3416145B2 (ja) 2003-06-16
CN1104899C (zh) 2003-04-09
AR005147A1 (es) 1999-04-14
MA24035A1 (fr) 1997-07-01
UA56151C2 (uk) 2003-05-15
IS2010B (is) 2005-05-13
SI0868183T1 (en) 2002-04-30
ATE212551T1 (de) 2002-02-15
HUP9903726A2 (hu) 2000-04-28
TW449475B (en) 2001-08-11
DZ2146A1 (fr) 2002-10-23
MX9805026A (es) 1998-09-30

Similar Documents

Publication Publication Date Title
GT199600098A (es) Formulaciones de quinolona inyectables.
ATE90570T1 (de) Verbesserte formulierungen mit kontrollierter abgabe.
ES2152485T3 (es) Procedimiento para preparar comprimidos que contienen amoxicilina y clavulanato recubiertos de una pelicula polimerica acuosa.
AR030707A1 (es) 9-ALFA-CLORO-6-ALFA-FLUOR-17-ALFA-HIDROXI-16-METIL-17-BETA-METOXICARBONIL-ANDROST-1,4-DIENOS, UN PROCESO PARA SU PREPARACIoN , COMPOSICION FARMACEUTICA, Y EL USO DEL MISMO PARA LA FABRICACION DE MEDICAMENTO
NZ330369A (en) aqueous medicaments containing 9-hydroxy-risperidone fatty acid ester
CO4520281A1 (es) Antifungicos de tetrahidrofurano
ES2074513T3 (es) Utilizacion de un antagonista opiaceo para la preparacion de una composicion farmaceutica para administracion transdermica y dispositivo para el suministro percutaneo.
ES2102132T3 (es) Amidas de acidos carboxilicos heterociclicos sustituidos, su preparacion y su utilizacion como medicamentos.
EA199700267A1 (ru) Применение фумагиллола и его производных для приготовления антиинфекционных интестинальных препаратов и фармацевтическая композиция на их основе
KR910009240A (ko) 약제학적 또는 치료학적 활성제의 수송 시스템
ES2087916T3 (es) Derivado de pirimidina biciclico, metodo para producir el mismo, y preparacion farmaceutica que contiene el mismo como ingrediente activo.
EA199700201A1 (ru) Парентеральные фармацевтические композиции, содержащие алкиламмониевые соли 2-арилпропиновых кислот
KR910000703A (ko) 테트라졸 자극성 아미노산 수용체의 길항물질
PT96303A (pt) Processo para a preparacao de novos derivados do acido piperidinocarboxilico com accao anestesica local e analgesica e de composicoes farmaceuticas que os contem
ES2135429T3 (es) Derivados de ciclohexano sustituidos para el tratamiento de enfermedades.
PT921787E (pt) Regime de administracao de inibidores de atpase de h',k'
RU93045145A (ru) Замещенные производные циклогексана и их применение для лечения заболеваний, содержащее их лекарственное средство
ES2086515T3 (es) Sal de codeina de un acido carboxilico substituido, procedimiento para su obtencion, su empleo y preparados farmaceuticos.
ATE246192T1 (de) Ethyliden-derivate tricyclyscher carbapenems
PT736029E (pt) Sulfamatos de pseudofructopiranose anticonvulsivos
DE68917937D1 (de) Verbindungen mit magensäureinhibitorwirkung und verfahren zur herstellung.
PT89729A (pt) Processo para a preparacao de derivados de cefalosporina e de composicoes farmaceuticas que os contem
ES2139965T3 (es) Benzoilguanidinas sustituidas con grupos de caracter basico, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene.
MX9301361A (es) Derivados de carbapenema antimicrobianos y su preparacion.
FI893677A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 6-fluori-3,5-dihydroksikarboksyylihappojen ja niiden johdannaisten valmistamiseksi